Correspondence regarding, "The Psychopharmacology of Depression in the Managed Care Setting"ByRichard L. Brown, MD, MPH,Laura A. Saunders, MSSW,Author reply by Norman Sussman, MD and Ricardo Castaneda, MDJanuary 1st 1997
Implications of Managed Care Denials for Pediatric Inpatient CareByNarendra Kini, MD,Robert TimberlakeJanuary 1st 1997
Cost-Effectiveness of Sumatriptan in a Managed Care PopulationByRandall F. Legg, BPharm, MBA,David A. Sclar, PhD,Neil L. Nemec, MD,John Tarnai, PhD,John I. Mackowiak, PhDJanuary 1st 1997
A Cost-Effective Approach to the Use of Selective Serotonin Reuptake Inhibitors in a Veterans Affairs Medical CenterByTony Singletary, PharmD,Donald S. North, PharmD,Malcolm Weiss, MSPH, PharmD,Gerry Marman, RPhJanuary 1st 1997
An Innovative Approach to Reducing Medical Care Utilization and ExpendituresByDavid W. Orme-Johnson, PhD,Robert E. Herron, PhDJanuary 1st 1997
The Relationship and Tensions Between Vertical Integrated Delivery Systems and Horizontal Specialty NetworksByThomas S. Harbin, Jr., MD, MBAJanuary 1st 1997
Managed Care Organizations Should Not Disclose Their Physicians' Financial IncentivesByGenevieve C. Noone,Peter A. Ubel, MDJanuary 1st 1997
To Tell the Truth: Disclosing the Incentives and Limits of Managed CareByE. Haavi Morreim, PhDJanuary 1st 1997
Theoretical Framework for Implementing a Managed Care Curriculum for Continuing Medical Education -- Part IByLinda Mast, MBAJanuary 1st 1997
Application of the Problem-Based Learning Model for Continuing Professional Education: A Continuing Medical Education Program on Managed Care Issues -- Part IIByLinda Mast, MBAJanuary 1st 1997
Bridging the Gap Between Managed Care and Academic Medicine: An Innovative FellowshipByRalph O. Bischof, MD,Robin L. Smith, MD,David B. Nash, MD, MBA,James F. Murray, PhD,Daniel Z. Louis, MS,Nicholas A. Hanchak, MD,Neil SchlackmanJanuary 1st 1997
The Impact of Physician Economic Incentives on Admission Rates of Patients with Ambulatory Sensitive Conditions: An Analysis Comparing Two Managed Care Structures and Indemnity InsuranceByGordon W. Josephson, MD,Anita Karcz, MD, MBAJanuary 1st 1997
Medical Liability Risk Avoidance: A Case for Adopting the International Normalized Ratio (INR) SystemBySandra S. Kline, PharmD,Maureen O. Atkins, JDJanuary 1st 1997
Patterns of Anti-Inflammatory Therapy in the Post-Guidelines Era: A Retrospective Claims Analysis of Managed Care MembersByDeborah A. Buchner, PhD,Angeline M. Carlson, PhD,David A. Stempel, MDJanuary 1st 1997
